Clofibrate
Known By Tradename :
Clofibrate Capsules, Clofibrate Softgels,
|
Companies That Produce This Drug :
Banner Pharmacaps Canada Ltd, Canada
Cardinal Health 409 Inc, United States
Major Pharmaceuticals Inc, United States
Novopharm Ltd, Canada
|
What It Is Used For :
Fibric Acid Derivatives (Antilipid Agents)
|
Known Precautions and Warnings :
Atorvastatin Calcium interacts with Clofibrate
Avoid this drug combination if possible. This drug combination, however, may be beneficial in patients with severe hyperlipidemias. Monitor patients for signs of muscle pain and weakness.
Resulting In: Rhabdomyolysis Concomitant use of Atorvastatin Calcium and Clofibrate can potentiate some adverse effects.
Clofibrate interacts with Ethinyl Estradiol/Drosperinone
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Ethinyl Estradiol/Drosperinone can reduce the effectivness of Clofibrate.
Clofibrate interacts with Ethinyl Estradiol/Ethynodiol Diacetate
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Ethinyl Estradiol/Ethynodiol Diacetate can reduce the serum levels and the effectiveness of Clofibrate.
Clofibrate interacts with Ethinyl Estradiol/Levonorgestrel
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Ethinyl Estradiol/Levonorgestrel can reduce the serum levels and the effectiveness of Clofibrate.
Clofibrate interacts with Ethinyl Estradiol/Norethindrone
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Ethinyl Estradiol/Norethindrone can reduce the serum levels and the effectiveness of Clofibrate.
Clofibrate interacts with Ethinyl Estradiol/Norethindrone Acetate
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Ethinyl Estradiol/Norethindrone Acetate can reduce the serum levels and the effectiveness of Clofibrate.
Clofibrate interacts with Ethinyl Estradiol/Norgestimate
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Ethinyl Estradiol/Norgestimate can reduce the serum levels and the effectiveness of Clofibrate.
Clofibrate interacts with Ethinyl Estradiol/Norgestrel
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Ethinyl Estradiol/Norgestrel can reduce the serum levels and the effectiveness of Clofibrate.
Clofibrate interacts with Norethindrone Acetate
Monitor serum lipoprotein concentration when using this drug combination. If CLOFIBRATE acitivity is lost, consider discontinuing ORAL CONTRACEPTIVE or increasing the dose of CLOFIBRATE.
Norethindrone Acetate can reduce the serum levels and the effectiveness of Clofibrate.
Clofibrate interacts with Probenecid
Observe patient for signs of CLOFIBRATE toxicity. May need to lower the dose of CLOFIBRATE.
Probenecid may increase serum levels of Clofibrate.
Clofibrate interacts with Rifampin
Monitor lipids level. May need to increase CLOFIBRATE dosage or discontinue RIFAMPIN.
Rifampin may increase the clearance of Clofibrate.
Clofibrate interacts with Simvastatin
Avoid this drug combination if possible. This drug combination, however, may be beneficial in patients with severe hyperlipidemias. Monitor patients for signs of muscle pain and weakness. Max dose is10mg/day.
Resulting In: myopathy Concomitant use of Clofibrate and Simvastatin can potentiate some adverse effects.
Ethinyl Estradiol/Etonogestrel interacts with Clofibrate
Monitor patient's response and adjust dose as needed.
Ethinyl Estradiol/Etonogestrel may reduce serum levels of Clofibrate.
Fluvastatin interacts with Clofibrate
Avoid this drug combination if possible. This drug combination, however, may be beneficial in patients with severe hyperlipidemias. Monitor patients for signs of muscle pain and weakness.
Resulting In: Rhabdomyolysis Concomitant use of Fluvastatin and Clofibrate can potentiate some adverse effects.
Lovastatin interacts with Clofibrate
Avoid this drug combination if possible. This drug combination, however, may be beneficial in patients with severe hyperlipidemias. Monitor patients for signs of muscle pain and weakness. Max dose is 20mg/day.
Resulting In: Rhabdomyolysis Concomitant use of Lovastatin and Clofibrate can potentiate some adverse effects.
Pravastatin interacts with Clofibrate
Avoid this drug combination if possible. This drug combination, however, may be beneficial in patients with severe hyperlipidemias. Monitor patients for signs of muscle pain and weakness.
Resulting In: Rhabdomyolysis Concomitant use of Pravastatin and Clofibrate can potentiate some adverse effects.
|
|
